Top Bayer Investors Demand Plan to End Long-Running Crisis
This article is for subscribers only.
Two prominent German investors voiced exasperation over Bayer AG’s recurring struggles, demanding a clearer path out of the conglomerate’s crises ahead of the annual shareholder meeting on Friday.
Deka Investment’s Ingo Speich characterized the current results of Chief Executive Officer Bill Anderson’s two-year tenure as “disastrous,” pointing to the falling stock price, stubbornly high debt levels and US legal problems. Once an icon of German industry, Bayer is now “at a strategic dead end,” Speich said in prepared remarks ahead of the meeting. Deka is a top 20 investor in Bayer.